Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Codexis is expected to supply biocatalysis screening products and services to Dainippon Sumitomo Pharma (DSP), under an agreement signed between the companies.
Subscribe to our email newsletter
Codexis is a clean technology company that develops of optimized biocatalysts that make industrial processes faster, cleaner and more efficient.
As per the pact, DSP will use Codexis’ biocatalysis screening products in selected undisclosed therapeutic products in its development pipeline.
Codexis Pharmaceutical Services and Enzyme Products president Joseph Sarret said DSP has identified Codexis technology as a key component in its drive to develop green, sustainable manufacturing processes to serve their key markets, and they look forward to a productive partnership.